Funds and ETFs DBV Technologies S.A. Nasdaq

Equities

DBVT

US23306J1016

Pharmaceuticals

Market Closed - Nasdaq 21:00:00 30/04/2024 BST 5-day change 1st Jan Change
0.6616 USD -4.28% Intraday chart for DBV Technologies S.A. -2.71% -30.56%

ETFs positioned on DBV Technologies S.A.

Name Weight AuM 1st Jan change Investor Rating
0.03% 0 M€ 0.00% -
0.02% 0 M€ 0.00% -
DBV Technologies specializes in developing solutions for diagnosing and treating food allergies (primarily to peanuts and cow's milk) using a patch (Viaskin®) that administers active ingredients into the top layers of the skin.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
1.244 EUR
Average target price
4.783 EUR
Spread / Average Target
+284.51%
Consensus
  1. Stock Market
  2. Equities
  3. DBV Stock
  4. DBVT Stock
  5. Funds and ETFs DBV Technologies S.A.